"10.1371_journal.pone.0121627","plos one","2015-04-02T00:00:00Z","Vicki A Johnson; Andrew H Kemp; Robert Heard; Christopher J Lennings; Ian B Hickie","Clinical Research Unit, Brain & Mind Research Institute, University of Sydney, 100 Mallet Street, Camperdown, 2050, Sydney, Australia; University Hospital and Faculty of Medicine, University of São Paulo, São Paulo, Brazil; School of Psychology & Discipline of Psychiatry, University of Sydney, Sydney, Australia; Lennings Seidler Collins Psychology: Clinical and Forensic Psychology Services, Level 5, 154 Elizabeth St., Sydney, Australia and Faculty of Policing and Law Enforcement, Charles Sturt University, Sydney, Australia","Conceived and designed the experiments: VJ AK IH CL RH. Performed the experiments: VJ. Analyzed the data: VJ AK CL RH IH. Contributed reagents/materials/analysis tools: VJ CL AK IH RH. Wrote the paper: VJ AK CL IH.","Vicki Johnson, Andrew Kemp, Robert Heard, Christopher Lennings and Ian Hickie report no financial interests or potential conflicts of interest. Ian B. Hickie is a Board Member of Psychosis Australia Trust. From 2012, he is a Commissioner in Australia’s new National Mental Health Commission. He was until January 2012 a director of headspace: the national youth mental health foundation. He has received honoraria for presentations of his own work at educational seminars supported by a number of nongovernment organisations and the pharmaceutical industry (including Pfizer, Servier and Astra Zeneca). He has served on advisory boards convened by the pharmaceutical industry in relation to specific antidepressants, including nefazodone, duloxetine and desvenlafaxine. He leads an investigator-initiated study of the effects of agomelatine on circadian parameters (supported in part by Servier but also by other NHMRC funding) and has participated in a multicentre clinical trial of the effects of agomelatine on sleep architecture in depression. Andrew Kemp is a PLOS ONE Editorial Board member. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.",30,12,4,"2015","04","Vicki A Johnson","VAJ",5,TRUE,5,1,5,4,TRUE,TRUE,FALSE,0,NA,FALSE
